Why Multimodal AI is Essential for Clinical Screening Accuracy

Is limited data hurting your clinical insights? **Multimodal AI** offers a complete view of patient health, improving screening accuracy in PAC/LTC. By integrating speech, visual cues, and history, GIA™ sharpens detection of conditions, enabling earlier intervention and better outcomes. GIA™ uses **multimodal AI** to improve screening, helping clinicians focus on patient care. GIA™ screens for **46 conditions** and leverages the power of **digital human** technology.

How Does **Multimodal AI** Improve Clinical Screening?

Single-modality approaches rely on one data source, such as questionnaires or basic observations, which can lead to incomplete assessments. **Multimodal AI** combines various data inputs, including speech patterns, facial expressions, and behavioral cues, providing a more holistic view. For example, GIA™ analyzes over 2,500 speech biomarkers and 436 visual data points during a brief conversation. This allows her to detect subtle indicators of conditions like depression (AUC 0.816) and PTSD (AUC 0.800) that might be missed by traditional methods. The combination of these data points offers a far more accurate and sensitive screening process, supporting clinicians in making better-informed decisions. This is crucial in PAC/LTC settings, where residents may have difficulty articulating their symptoms or have co-occurring conditions that complicate diagnosis.

What Specific Data Points Does GIA™ Use for **Multimodal Screening**?

GIA™ integrates several data modalities to enhance screening accuracy. Speech biomarkers are a key component, analyzing subtle changes in tone, pace, and vocabulary that can indicate cognitive or emotional distress. Visual data, captured through a Samsung Health Grade Galaxy device, assesses facial expressions, eye contact, and body language. Patient history, pulled from EHR integrations, provides crucial context. By combining these data streams, GIA™ creates a comprehensive patient profile. For instance, in Parkinson's screening (AUC 0.97), GIA™ analyzes speech patterns for tremors and rigidity while observing facial expressions for signs of masking. This multimodal analysis helps clinicians identify potential issues quickly and efficiently, supporting earlier intervention and improved care planning. All results are reviewed and approved by a clinician.

What clinical benefits result from faster, more accurate screening?

Faster and more accurate screening can have a significant impact on patient outcomes and facility operations. Early detection of conditions like depression, anxiety, and PTSD can lead to timely interventions, preventing these conditions from worsening and reducing the need for costly hospitalizations. GIA™ completes a screening in 40 seconds, with results available in under 2 minutes, allowing clinicians to focus on care delivery. By detecting potential health issues early, facilities can also improve their Five-Star Quality Ratings, attract more referrals, and maintain a higher census. The ability to identify subtle changes in a resident's condition also allows for proactive care planning, leading to a better quality of life. While GIA™ does not diagnose, treat, or prescribe, she provides valuable data that supplements clinical judgment, leading to a more informed and effective approach to patient care. All results are reviewed and approved by a clinician.

How does multimodal AI overcome the limitations of traditional assessments?

Traditional assessments often rely on subjective observations and patient self-reporting, which can be unreliable due to cognitive impairment, communication difficulties, or reluctance to disclose sensitive information. **Multimodal AI** overcomes these limitations by incorporating objective data from multiple sources. For instance, GIA™ can detect subtle changes in speech patterns that may indicate cognitive decline, even if the resident appears alert and oriented. The platform's ability to analyze visual cues can also reveal signs of distress or discomfort that the resident may not express verbally. By providing a more objective and comprehensive assessment, multimodal AI reduces the risk of missed diagnoses and ensures that residents receive the appropriate care. GIA™ speaks 92 languages, which can help patients feel more comfortable during screening, leading to more accurate results.

Conclusion

**Multimodal AI** offers a powerful way to improve **clinical screening** in post-acute and long-term care. By combining diverse data sources, Scienza Health's GIA™, powered by digitalhumanOS™, provides a more complete and accurate picture of a resident's health, supporting clinicians in making better-informed decisions and delivering more effective care. With shrinking hospital margins, how can medical directors optimize screening for better patient outcomes?